News summary

NorthStrive’s muscle probiotic gets mixed results in mice

Source: Longevity Technology • Published: 19 Nov 2026, 18:00

Summarized by Masters of Longevity from Longevity Technology.

Preclinical mouse study found limited benefits from the probiotic plus semaglutide.

NorthStrive’s muscle probiotic gets mixed results in mice
Key Takeaways
  • An engineered probiotic was tested in mice with semaglutide.
  • Results were mixed and showed only a few positive signals.
  • The company plans a repeat study at a lower drug dose.
Read the full article at Longevity Technology ↗

Continue exploring

Recommended MoL Picks

MoL PickReducing Inflammation from Ageing Cells: What a Mouse Study FoundResearchers reduced the inflammatory signals released by cells that had stopped dividing. Older mice also improved on some strength and frailty tests. Whether this approach could help people remains unknown.MoL PickSemaglutide Extended Lifespan in Mice. What Would Make It a Human Longevity Drug?A new animal study sharpens an important question: when do benefits in a particular disease become evidence for a longer, healthier life?MoL PickGrowth Hormone Receptor Deletion Extends Mouse LifespanStudy summary: researchers switched off the growth hormone receptor in middle-aged mice and followed survival and physical function.